It was Dr. Oly Ilunga, Minister of Health who, together with Prof. Jean-Jacques Muyembe, director of the National Institute for Biomedical Research (INRB) during the press briefing on Saturday, September 8, 2018. Research has shown that the Ebola virus circulates throughout Africa and especially in the DRC. That is why you have to be vigilant and make an alarm in time.
Thanks to the techniques available at the INRB, according to the minister, it has been established that there is no connection between the situation of Mangina and that of Bikoro. The first is a species that comes close to the Ebola Zaire species that Likati occupied in 2017, while that of Bikoro in 2014 was close to the Djera epidemic and also close to that of Kikwit in 1995.
about the answer, he said that the country has opted for the pillar strategy, is a Congolese registered trademark with which a coordinated response is possible in which the roles of the actors are perfectly defined on the ground in order to have a very good coordination of all interventions . The most important thing is to have strong leadership from the government, with a series of actors who all act around a response that is unique and in consultation.
But the main pillar is the epidemiological surveillance that makes it very quickly possible to detect a suspicious case, to investigate the link, contacts and follow-up contacts, to determine the incubation time 21 days. The other pillar is the therapeutic management of patients confirmed in the Ebola Treatment Center (ETC), provided by the National Program of Emergencies of Humanitarian Actions. Added to this is the therapeutic aspect of the use of new molecules used by Prof. dr. Muyembe and his team.
Another pillar of the minister is vaccination, which is fundamental for breaking the transmission chain of the virus. The Ebola strategy is based on the quarantine principle. "This is not about physical quarantine, but about the confirmed case, the contact and the contact of his contacts with the aim of interrupting the transmission," he says. To date, 6,820 people have already been vaccinated by teams that are already working as soon as a case is confirmed. While those who have been vaccinated in Kinshasa, on the other hand are health professionals, journalists and other people who want to get on the ground.
For North Kivu, however, it is the safety aspect that deserves to be taken into account in this corner of the Republic as prey for insecurity areas. As a result, the Security Committee should work together with others in a coordinated way, based on a commitment at Community level.
Another problem is mobility. The largest is between Beni and Mangina, then Beni and Butembo. This is why invigilator teams work hard to find out if the warning is confirmed or not.
To fight three Epidemiological Treatment Centers (ETCs) are operational, including Beni, Mangina and Goma. The latter is operational, although no case has been reported. It is important to anticipate the treatment to avoid eventuality.
The team faces a number of challenges related to community resistance. The minister indicates that most cases that postpone the end of the epidemic are related to the Ndindi district, the main focus of the second wave which is responsible for the last confirmed cases. It was necessary to involve street leaders, neighborhoods, avenues, customs and governing bodies in the young to achieve this.
The other challenge is the fear of the population, so that back to school is effective, while schools are not closed.
Moreover, it is the protection of health professionals who become a reinforcement factor if this is not properly insured. Here, the Minister insists on respect for preventive measures and control of infections, as well as hygiene measures. he nonetheless regrets the low diploma awarded to health professionals throughout the republic.
The Prof. dr. Muyembe, director of INRB reports that a great experience has been developed. During this epidemic, it is the first time that molecules are used that have not yet been approved by the World Health Organization, but are authorized to use them in a conventional manner. Three of these five molecules are used to facilitate administration. At the moment, 26 patients have been treated and 15 have been cured, six have died and five are still under treatment. "It is encouraging for us," he says, because there is now a chance to treat and cure the Ebola case. This is not to say that we should abandon simple public health measures.
He warns that if the disease is treated early, there is a good chance to heal the patient. This, understood that there is no way to overcome the epidemic of the Ebola epidemic without the support of the community.